查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589605

药物检测市场：按药物检测产品、样本类型和最终用户划分 - 全球预测 2025-2030

Drug Testing Market by Drug Testing Product (Assay Kits, Consumables, Drug Screening Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药检市场规模为222.5亿美元，预计2024年将达到249.4亿美元，复合年增长率为12.18%，到2030年将达到497.6亿美元。

药物检测的范围在于其在职场安全、竞技运动合规性和促进康復方面的重要作用。药物测试被定义为对生物样本进行分析以确定特定物质的存在，对于维持职业安全标准、法规遵循和个人责任是必要的。应用涵盖医疗保健、执法、体育和企业等领域，最终用途涵盖从交通运输到体育等多种行业。药物检测市场的成长主要是由于药物滥用的增加、更严格的监管要求以及雇主对确保安全环境和提高生产力的要求不断增加而推动的。先进技术的发展正在出现关键的成长机会，例如快速和非侵入性测试方法，反映了消费者对效率和隐私的偏好。市场相关人员应该投资于人工智慧和机器学习整合的研究，以获得更快、更准确的测试结果。然而，挑战包括道德隐私问题、先进检测套组的高成本以及因地区而异的法律复杂性。此外，测试结果的潜在错误和某些测试的有限范围进一步阻碍了市场成长。在技​​术创新方面，市场将受益于区块链的安全资料处理和生物标记发现，以提高测试特异性。此外，便携式数位测试设备的引入有可能彻底改变个人和组织的合规管理。药物检测市场本质上是竞争性的，不断的进步和监管变化维持着动态的市场环境。企业需要根据不断变化的监管环境和技术进步调整策略，以利用现有机会并有效填补现有空白。透过建立策略伙伴关係并扩大我们的服务范围，我们相信我们能够应对市场的复杂性并促进这一重要产业的永续成长。

主要市场统计
基准年[2023] 222.5亿美元
预测年份 [2024] 249.4亿美元
预测年份 [2030] 497.6亿美元
复合年增长率（%） 12.18%

市场动态：揭示快速发展的药物测试市场的关键市场洞察

供需的动态交互作用正在改变药物检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 毒品和酒精消费量增加
    • 关于药物和酒精测试的严格政府法规
    • 监管核准和产品/服务开发迅速增加
  • 市场限制因素
    • 药物测试在一些国家受到限制，因为它侵犯了隐私权。
  • 市场机会
    • 开发先进的药物测试解决方案
    • 智慧指纹药品检测系统
  • 市场挑战
    • 筛检测试解释中的技术和社会问题

波特五力：驾驭药物测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物检测市场的外部影响

外部宏观环境因素对药品检验市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药检市场的竞争格局

对药物测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵药物测试市场供应商绩效评估

FPNV定位矩阵是评估药检市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药物测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，药物测试市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 药物和酒精消耗增加
      • 关于药物和酒精测试的严格政府法规
      • 监管核准以及产品和服务开发的快速增加
    • 抑制因素
      • 药物测试在一些国家受到限制，因为它侵犯了隐私权
    • 机会
      • 开发先进的药物测试解决方案
      • 智慧指纹药品检测系统
    • 任务
      • 筛检测试解释中的技术和社会问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品检验市场产品药品检验

  • 检测试剂套件
  • 消耗品
  • 药物检测服务
  • 产品
    • 分析设备
      • 酒精检测仪
      • 层析法设备
      • 免疫检测分析仪
    • 校准器和控制装置
    • 快速检测装置
      • 口腔液检测装置
      • 尿液检查装置
    • 样本采集管

第七章 药品检验市场（依样本型）

  • 呼吸样本
  • 头髮样本
  • 口腔液样本
  • 尿液样本

第八章 药物测试市场：依最终使用者分类

  • 刑事司法系统与执法
  • 药物检测实验室
  • 戒毒治疗中心
  • 医院
  • 个人用户
  • 疼痛管理中心
  • 大学
  • 职场

第九章美洲药检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲药检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Legacy Medical Services, LLC.
  • Omega Laboratories, Inc.
  • Quest Diagnostics
  • Quidel Corporation
  • Sciteck Clinical Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-B973EDD5EB02

The Drug Testing Market was valued at USD 22.25 billion in 2023, expected to reach USD 24.94 billion in 2024, and is projected to grow at a CAGR of 12.18%, to USD 49.76 billion by 2030.

The scope of drug testing lies in its crucial role in promoting workplace safety, compliance in competitive sports, and rehabilitation. Defined as the analysis of biological samples to identify the presence of specific substances, drug testing is necessary for maintaining occupational safety standards, legal compliance, and personal responsibility. Its applications are vast, spanning sectors like healthcare, law enforcement, sports, and corporate, with end-use encompassing diverse industries from transportation to athletics. The drug testing market's growth is primarily fueled by increased substance abuse, stringent regulatory requirements, and greater employer demand to ensure safer environments, enhancing productivity. Key growth opportunities are emerging with the development of advanced technology like rapid and non-invasive testing methods, reflecting consumer preferences towards efficiency and privacy. Market players should invest in research targeting the integration of AI and machine learning for quicker, more accurate test results. However, challenges include ethical concerns regarding privacy, the high cost of advanced testing kits, and legal complexities across different regions. The potential for error in test results and the limited scope of specific tests further hinder market growth. In terms of innovation, the market can benefit from exploring blockchain for secure data handling and biomarker discovery for enhanced testing specificity. Furthermore, the introduction of portable and digital testing devices could revolutionize personal and organizational compliance management. The nature of the drug testing market is competitive, with continuous advancements and regulatory changes maintaining dynamic market conditions. Companies need to tailor their strategies to the evolving legislative landscape and technological advancements to capitalize on existing opportunities and bridge existing gaps effectively. Engaging in strategic partnerships and expanding service offerings could help navigate market complexities and foster sustainable growth in this essential industry.

KEY MARKET STATISTICS
Base Year [2023] USD 22.25 billion
Estimated Year [2024] USD 24.94 billion
Forecast Year [2030] USD 49.76 billion
CAGR (%) 12.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Testing Market

The Drug Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing drug & alcohol consumption
    • Stringent government regulations for drug & alcohol testing
    • Surge in regulatory approvals and product & service development
  • Market Restraints
    • Restriction on the drug testing as it is violation of privacy rights in some countries
  • Market Opportunities
    • Development of advanced drug testing solutions
    • Intelligent fingerprint drug testing system
  • Market Challenges
    • Technical problem in interpreting screening tests and social issue

Porter's Five Forces: A Strategic Tool for Navigating the Drug Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Testing Market

A detailed market share analysis in the Drug Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Testing Market

A strategic analysis of the Drug Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Legacy Medical Services, LLC., Omega Laboratories, Inc., Quest Diagnostics, Quidel Corporation, Sciteck Clinical Laboratories, Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Testing Product, market is studied across Assay Kits, Consumables, Drug Screening Services, and Products. The Products is further studied across Analytical Instruments, Calibrators & Controls, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices.
  • Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
  • Based on End-User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Universities, and Workplace.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing drug & alcohol consumption
      • 5.1.1.2. Stringent government regulations for drug & alcohol testing
      • 5.1.1.3. Surge in regulatory approvals and product & service development
    • 5.1.2. Restraints
      • 5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced drug testing solutions
      • 5.1.3.2. Intelligent fingerprint drug testing system
    • 5.1.4. Challenges
      • 5.1.4.1. Technical problem in interpreting screening tests and social issue
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Testing Market, by Drug Testing Product

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Consumables
  • 6.4. Drug Screening Services
  • 6.5. Products
    • 6.5.1. Analytical Instruments
      • 6.5.1.1. Breathalyzers
      • 6.5.1.2. Chromatography Instruments
      • 6.5.1.3. Immunoassay Analyzers
    • 6.5.2. Calibrators & Controls
    • 6.5.3. Rapid Testing Devices
      • 6.5.3.1. Oral Fluid Testing Devices
      • 6.5.3.2. Urine Testing Devices
    • 6.5.4. Sample Collection Tubes

7. Drug Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Universities
  • 8.9. Workplace

9. Americas Drug Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Alfa Scientific Designs, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Clinical Reference Laboratory, Inc.
  • 6. Cordant Health Solutions
  • 7. Dragerwerk AG & Co. KGaA
  • 8. F. Hoffmann-La Roche AG
  • 9. Legacy Medical Services, LLC.
  • 10. Omega Laboratories, Inc.
  • 11. Quest Diagnostics
  • 12. Quidel Corporation
  • 13. Sciteck Clinical Laboratories
  • 14. Siemens Healthineers AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 289. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2023